Matthew Wiley - Chief Commercial Officer at BioXcel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
BTAI on Nasdaq
All Insider Reports
All Insider Reports

Matthew Wiley - trading volume in the past year for BioXcel Therapeutics, Inc.

Holdings reported by Matthew Wiley for BioXcel Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 19K $10.5K $0.55 Oct 3, 2024 Direct
Restricted Stock Units 7.5K $9.6K $1.28 Sep 15, 2024 Direct Common Stock

Transactions reported by Matthew Wiley for BioXcel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.